Skip to content

Insider · CIK 0002011766

Jeffrey L. Feike

director

Files at TVGN (Tevogen Bio Holdings Inc.). First filing -, latest -.

In brief

Jeffrey L. Feike files SEC Form 4 as director at TVGN (Tevogen Bio Holdings Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Jeffrey L. Feike has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026TVGN
Tevogen Bio Holdings Inc.
AGrant or award
Common Stock
+75,000$0.00$0131,43528 d ago
Jul 10, 2026TVGN
Tevogen Bio Holdings Inc.
AGrant or award
Common Stock
+40,000$0.00$056,435Jul 10, 2026
Dec 23, 2024TVGN
Tevogen Bio Holdings Inc.
AGrant or award
Common Stock
+240,000$0.00$0821,771Dec 26, 2024

Questions about Jeffrey L. Feike

Answered from the filings on this page, as of the latest one.

Is Jeffrey L. Feike buying or selling?

Jeffrey L. Feike has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Jeffrey L. Feike's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey L. Feike has 0.

Where does Jeffrey L. Feike file Form 4?

Jeffrey L. Feike has filed Form 4 at TVGN (Tevogen Bio Holdings Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jeffrey L. Feike: insider trades and track record | InsiderTell